Visalytics
Visalytics
approved EB-2 (NIW)

Ph.D. Candidate

Biology · China · 2025-02-15

Processing Time
64 days
Decision Date
2025-02-15
Location
California
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop and implement advanced synthetic biology and genetic engineering techniques to precisely control gene expression and cellular behavior in mammalian cells. Her work aims to enhance therapeutic applications and biotechnological advancements to address critical healthcare challenges, specifically rising cancer rates in the U.S.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses critical healthcare challenges and cancer treatment, which are of significant national importance to U.S. public health.

2 Well-positioned to Advance the Endeavor Met

The petitioner's publication record, 95 citations, and support from major federal funding agencies demonstrate her ability to advance the field.

3 Waiver Benefit to the U.S. Met

On balance, the petitioner's specialized skills in genetic engineering and synthetic biology provide a benefit that outweighs the need for labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 3 peer-reviewed journal articles in highly ranked journals and 95 citations. Evidence included research funding from DARPA, NIH, ADC, and NSF, along with 4 expert recommendation letters confirming her leadership in epigenetics. These credentials satisfied all three prongs of the Dhanasar framework.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Original Contributions
Government Alignment

Similar Cases

Research Scientist

Biotechnology · Germany

WeGreened EB-2 (NIW) approved
Connecticut 29 days 2023-07-19
The petitioner proposes to continue research into the structural basis of epigenetic modifiers to develop innovative therapeutic interventions for genetic disorders. This work involves the biochemical and structural characterization of recombinant proteins to better understand gene regulation and disease mechanisms. The endeavor aims to advance precision medicine through the development of diagnostic tools for conditions associated with abnormal DNA methylation patterns.
View Case

Postdoctoral Researcher

Biotechnology · South Korea

WeGreened EB-2 (NIW) approved
California 249 days 2025-05-28
The petitioner proposes to develop advanced biological tools for genetic and molecular cell interfacing, specifically focusing on high-precision CRISPR base editors and synthetic protein biomarkers. This work aims to refine viral vector delivery systems to enable targeted, non-invasive gene therapies for complex neurological diseases.
View Case

Research Scientist

Biotechnology · Malaysia

WeGreened EB-2 (NIW) rfe approved
California 216 days 2025-07-17
The petitioner proposes to develop and apply molecular and genome engineering tools, specifically gene-editing technologies, to study and treat human genetic disorders. This work includes managing microbiome-related diseases and enabling precise genetic interventions for patients with rare genetic conditions to advance personalized medicine.
View Case

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
Illinois 36 days 2025-09-05
The petitioner proposes to develop cutting-edge genomic technologies to understand the functions of non-coding RNAs. This research aims to uncover their roles in human disease and repurpose them as programmable tools for biotechnology and therapeutic applications.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-02-15.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 64 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist